Skip to main content

Table 2 Results from Meta-Analyses, FEV1 and AAT, Adult Cohorts

From: SERPINA1 methylation and lung function in tobacco-smoke exposed European children and adults: a meta-analysis of ALEC population-based cohorts

CpG

CpG Position

Gene Group

SAPALDIA

Meta- Analysis of Lung Function Association in SAPALDIA, NFBC and ECRHS

Circulating AAT

Cross-Sectional T1

Cross-Sectional T2

Repeat Cross-Sectional

Change

Coef.

P.valuea

Coef.

P.valuea

Directionb

Coef.

P.valuea

Directionb

Coef.

P.valuea

Directionb

Coef.

P.valuea

Directionb

cg10761141

94,844,776

3UTR

−0.30

0.25

0.75

0.13

+++

0.63

0.21

+ − +

−0.04

0.84

+ − –

0.02

0.48

+++

cg25042671

94,849,061

Body

−0.59

0.04

−0.72

0.25

− + −

− 0.80

0.21

– − −

−0.22

0.52

++−

−0.03

0.44

− + −

cg20267408

94,849,703

5UTR

−0.44

0.21

−0.15

0.82

++−

−0.05

0.94

++−

0.10

0.79

++−

0.00

0.97

+ − –

cg26938334

94,849,747

5UTR

1.16

0.42

− 0.01

0.99

− + −

− 0.35

0.74

− + −

− 0.33

0.34

– − +

− 0.01

0.71

– – –

cg16110645

94,850,433

5UTR

− 0.64

0.34

0.39

0.67

−++

0.55

0.59

+ − +

0.08

0.85

+ − +

−0.02

0.75

– − +

cg10832639

94,850,965

5UTR

−0.25

0.72

1.24

0.16

+++

0.01

0.99

−++

0.18

0.61

−++

0.00

0.95

++−

cg02126235

94,855,034

5UTR

−0.30

0.58

0.76

0.45

+++

0.67

0.55

++−

− 0.26

0.55

– – –

0.02

0.69

++−

cg22828990

94,855,099

5UTR

−0.09

0.82

0.19

0.79

– − +

0.30

0.68

– − +

0.69

0.03

+ − +

−0.09

0.04

– – –

cg09968361

94,855,344

5UTR

−0.33

0.44

1.43

0.04

+++

0.65

0.36

−++

0.72

0.02

+++

−0.10

0.01

–

cg13826459

94,855,505

TSS1500

−0.08

0.76

0.16

0.76

−++

0.98

0.05

+++

−0.05

0.83

− + −

0.04

0.15

+++

cg25968219

94,855,590

TSS1500

−1.81

0.05

3.29

0.003

+++

−1.29

0.37

– − +

0.37

0.59

++−

− 0.08

0.15

– − +

cg01606800

94,855,990

TSS1500

−1.08

0.001

0.47

0.47

−++

−0.13

0.85

– − +

− 0.11

0.73

– − +

− 0.01

0.75

– − +

cg02181506

94,856,984

1stExon

−0.78

0.08

0.11

0.89

– − +

0.65

0.40

+ − +

0.28

0.47

+ − +

0.02

0.71

+ − –

cg10070185

94,857,151

TSS200

−0.05

0.91

0.37

0.59

– − +

1.08

0.16

+++

0.24

0.39

−++

0.04

0.29

+ − +

cg24621042

94,857,275

TSS1500

−0.68

0.04

0.87

0.14

+++

1.16

0.06

+++

−0.15

0.60

− + −

− 0.01

0.87

+ − +

cg00802237

94,858,066

TSS1500

−0.07

0.81

−0.01

0.99

+ − –

− 0.48

0.40

– − +

0.12

0.67

+ − +

−0.03

0.35

– − +

cg04179148

94,858,339

TSS1500

−0.70

0.06

1.80

0.01

+++

0.29

0.67

+++

0.36

0.25

+++

−0.03

0.47

– – –

  1. Cross-sectional and repeat cross-sectional models adjusted for: study center, age, age2, education, height, height2, sex, sex*age, (sex*age) 2, sex*height, (sex*height)2, Bcell, CD4T, CD8T, Eos, Mono, NK. Repeat cross-sectional in addition ran with a random intercept on the subject. In predictive models, annual change in lung function was computed as the difference between T2 and T1 divided by time of follow-up: (T2-T1)/follow-up models adjusted for covariates from T1
  2. Sample size for circulating AAT for SAPALDIA n = 561. Cross-sectional and prediction models (change) n = 1076, and n = 1122 for repeat cross-sectional models
  3. Meta-Analysis of Lung Function Association of Methylation of CpGs in the SERPINA1* Gene with FEV1 Level and Decline in Adult Ever-Smokers from SAPALDIA, ECRHS and NFBC and with Circulating AAT Concentrations in SAPALDIA
  4. From SERPINA gene cluster located on chromosome 14 between positions: 94′641’781 and 95′235’125 (human genome build 37/hg19)
  5. aNominal P-values, Bonferroni corrected significance level for 119 tests is P-value 4.6 × 10− 4
  6. bDirection of effect for SAPALDIA, ECRHS and NFBC. A positive sign indicates that an increase in methylation is associated with higher level of lung function (cross-sectional models) and with an attenuation of lung function decline, respectively (change model)
  7. Statistically significant results are highlighted in bold